Chronic Kidney Disease Trial, Recruiting (NCT07146854)

Chronic Kidney Disease Trial, Recruiting NCT07146854 Sponsor: Phraxis, Inc. Condition: Chronic Kidney Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07146854 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Kidney Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older.
People who have end-stage kidney disease and need a new blood vessel graft created for dialysis.
People whose upper arm is a suitable location for placing the graft.
People (or their legal guardian) who understand the study and are willing and able to follow the dialysis schedule and attend required follow-up appointments.
People (or their legal guardian) who are willing to sign a written consent form agreeing to take part.

Who may not be able to join:

People for whom the EndoForce Connector System is medically unsuitable based on the manufacturer's guidelines (confirm with trial site).
People who are pregnant.
People who are already taking part in another dialysis or blood vessel research study, unless the organisation running this trial has given prior approval.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ari Kramer, MD, Spartanburg Regional Medical Center

Phone: 651-260-6673

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07146854

Sponsor: Phraxis, Inc.

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Kidney Disease

Trial contact: 651-260-6673

More information: https://clinicaltrials.gov/study/NCT07146854

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older.
People who have end-stage kidney disease and need a new blood vessel graft created for dialysis.
People whose upper arm is a suitable location for placing the graft.
People (or their legal guardian) who understand the study and are willing and able to follow the dialysis schedule and attend required follow-up appointments.
People (or their legal guardian) who are willing to sign a written consent form agreeing to take part.

Who may not be able to join:

People for whom the EndoForce Connector System is medically unsuitable based on the manufacturer's guidelines (confirm with trial site).
People who are pregnant.
People who are already taking part in another dialysis or blood vessel research study, unless the organisation running this trial has given prior approval.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Phraxis, Inc.

Registry

ClinicalTrials.gov

Start date

13 January 2026

Est. completion

1 December 2029

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Incidence of Treatment-Emergent Adverse Events; AVG Cumulative Patency; AVG Primary Patency; Number of AVG Interventions to Maintain Patency; Number of Participants with Acute Device Success

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov